Allergic contact dermatitis from buprenorphine

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 60, Issue 9, 2005, Pages 1217-1218

  Callejo Melgosa, A M ^a   Martinez J C ^a   Fuentes, M J ^a   Martin C ^a  

^a NONE

Author keywords

Buprenorphine; Contact dermatitis; Patch test; Transdermal delivery system

Indexed keywords

BUPRENORPHINE; CORTICOSTEROID;

AGED; ARTICLE; CANCER PAIN; CASE REPORT; CHRONIC PAIN; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG FORMULATION; FEMALE; HUMAN; PATCH TEST; PRIORITY JOURNAL; PRURITUS; SKIN ALLERGY; SYMPTOMATOLOGY;

ADMINISTRATION, CUTANEOUS; AGED; ANALGESICS, OPIOID; BUPRENORPHINE; DERMATITIS, ALLERGIC CONTACT; FEMALE; HUMANS; PATCH TESTS;

EID: 23844444156     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2005.00883.x     Document Type: Article

References (3)

1. Budd K. Buprenorphine and the transdermal system: the ideal match in pain management. Int J Clin Pract Suppl 2003;133: 9-14.
2. Lachapelle JM, Ale SI, Freeman S, Frosch PJ, Goh CL, Hannuksela M et al. Proposal for revised international standard series of patch test. Contact Dermatitis 1997;36: 121-123.
3. Evans HC, Easthope SE. Transdermal buprenorphine. Drugs 2003;63:1999-2010.